The promise of therapeutic camelid-nanobodies
30 July 2021 | By Bio-Techne
Watch this on-demand webinar and learn about robust technologies for nanobody drug discovery.
List view / Grid view
Stem cells are undifferentiated biological cells that can differentiate into specialised cells and can divide to produce more stem cells.
30 July 2021 | By Bio-Techne
Watch this on-demand webinar and learn about robust technologies for nanobody drug discovery.
JDRF funds development of an insulin-producing implant to regulate blood glucose levels in type 1 diabetes patients.
Depletion of ATP due to viral-induced CPE leads to a reduction in luminescence signal, enabling quantitation of viral-induced CPE in host cells.
28 July 2021 | By Sartorius AG
In this on-demand webinar, our expert illustrates the utility of GPCR libraries and explains how to discover potent functional antibodies against multiple GPCR targets.
A Swiss team have created a laboratory test that incorporates the placenta into embryotoxicity assessments without damaging foetuses.
New research has shown that the protein Piezo 1 prevented Treg cells from controlling the effects of inflammation in a multiple sclerosis mouse model.
Researchers have developed a 3D “assembloid” that presents a potential entry route of COVID-19 into the brain.
A team have developed a minimally invasive exosome spray that helped repair rat hearts after myocardial infarction.
Every manufacturing process for potential biologics begins with cell line development, whether it’s for clinical trials or a market launch.
10 reasons to choose Bethyl antibodies and reagents from Fortis Life Sciences for your applications.
Researchers have published a step-by-step protocol on how to produce millions of mature human cells in a chimeric mouse embryo.
As interest in biotherapeutic proteins grows, the need to reduce cell line development costs and the time to market is more critical than ever.
Learn quick technical tips to optimise your ELISA workflow, including how to: select the right ELISA kit, avoid contamination and normalise data.
In non-human primates, researchers have found that mesenchymal stem cells were effective at strengthening the immune response to HIV.
A team of scientists has found that a type of cell derived from human stem cells and widely used for brain research and drug development may have been leading researchers astray for years. Here, Dr Raphaël Lis from Weill Cornell Medicine explains how forcing the activity of three known endothelial cell transcription…